Loading stock data…
VATE
$16.65-2.45 (-12.83%)
After Hours$16.63-0.02 (-0.12%)· Last close Jun 9
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
INNOVATE Corp. in the Industrials sector is trading at $16.65 with a market capitalization of $176M. The stock is currently near its 52-week high of $19.59, remaining 146.3% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$16.65
Potential Downside
0%
Whystock Fair Value$16.65
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The company operates through the Infrastructure, Life Sciences, and Spectrum segments. The Infrastructure segment provides i...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$175.71M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
25.24%
Volume
Today's trading volume
102,208
Recent News
INNOVATE Q1 Loss Narrows Y/Y on Infrastructure, AI Project Demand
VATE's Q1 revenues jump 33% as AI-driven infrastructure demand boosts DBM Global, offsetting weakness in Spectrum and Life Sciences.
INNOVATE Corp. (VATE): 10 Best Performing NYSE Stocks So Far in 2026
INNOVATE Corp. (NYSE:VATE) is one of the best performing NYSE stocks so far in 2026. On May 14, INNOVATE reported a 33.0% increase in Q1 2026 consolidated revenue to $364.8 million, driven by its Infrastructure segment. The company narrowed its net loss to $17.2 million, or $1.29 per share, compared to $24.8 million in the […]
INNOVATE Q1 Earnings Call Highlights
INNOVATE (NYSE:VATE) reported higher first-quarter revenue and a narrower loss as growth in its infrastructure business offset weaker results in its Life Sciences and Spectrum segments, management said on the company’s first-quarter 2026 earnings call. Interim CEO Paul Voigt said the company delive
Innovate Corp (VATE) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Advances ...
Innovate Corp (VATE) reports a 33% revenue increase driven by infrastructure gains, while navigating challenges in Life Sciences and Spectrum segments.
INNOVATE Q4 Earnings Call Highlights
INNOVATE (NYSE:VATE) reported fourth-quarter and full-year 2025 results and provided updates across its infrastructure, life sciences, and spectrum segments, with management highlighting strong revenue growth led by DBM Global and several milestones at MediBeacon. The call was led by Interim CEO Pau